To Top

Community

Stephen A. Munk, Ph.D

Dr. Stephen Munk has been with Ash Stevens Inc. since 1997, serving as President since 1998 and CEO since 2001. He is experienced in drug discovery, development and manufacturing, both as a scientist and as a manager. Prior to joining Ash Stevens, Dr. Munk worked at Allergan, Inc. as a drug discovery scientist and subsequently as the co-team leader of the adrenergic drug discovery team. Under Dr. Munk’s stewardship, Dr. Munk is also an Adjunct Professor of Chemistry at Wayne State University and has served on the Board of Directors of MichBio.

Contribution
CDMO

Meeting Unmet Patient Needs with Small-Volume APIs

PAP-Q04-16-CL-003

Growing Demand for Small-Molecule CDMO Services

PAP-Q1-16-CL-004

What Does It Mean to be a Full-Service CDMO?

PAP-Q4-15-CL-002
Regulatory

How a CMO Can Help With Investigational New Drug Applications

PAP-APR-S01-CL-002